IP
Ipsen S.A.
IPSEF · OTC
$113.13 +0.00% (+$0.00)
Market Cap 8.16B €
P/E Ratio 18.36x
Div. Yield 1.64%
ROE 10.19%
Bulios Fair Price
$141.16
24.8% upside
Current Price
$113.13
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IPSEF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
89 /100
Cheap P/FCF 7.90x
P/E 18.36x
P/B 1.88x
Growth
41 /100
Stable FCF growth 12.85%
EPS growth 12.01%
Book val. growth 9.10%
Profitability
90 /100
Strong Op. margin 20.30%
Gross margin 70.58%
FCF margin 28.10%
Quality
52 /100
Average ROA 6.41%
ROIC 10.19%
Asset turnover 0.53x
Debt
100 /100
Low Int. coverage 20.67x
Debt/Equity 0.24x
Net debt/EBITDA -0.43x
Stability
69 /100
Stable EPS volatility 36.31%
Beta 0.32x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IPSEF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
David G. Loew
Employees
5,535
Headquarters
Paris
Upcoming events
11 FEB
Earnings
Upcoming earnings report